Follow the people · Insider
Mikheal Nassif
Mikheal Nassif files insider transactions with the SEC as a ceo of Neogen (NEOG). We hold 5 disclosed purchases and sales filed since 19 August 2025, 1 of them in the last 90 days.
- Files forNEOG
- Disclosed buys and sells5 in all, 1 in the last 90 days
- Last disclosure20 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 15 August 2025 — 19 August 2026CEO · Neogen (NEOG)17 Form 4 lines · source: SEC Form 4
Everything they disclosed
17 entries, newest first — one per disclosure report, one per Form 4 line- had shares withheld for tax on 20,397 shares of NeogenSEC Form 420 August 2026Restricted Stock Units · traded 19 August 2026 · filed 20 August 2026
- was granted 141,631 shares of NeogenSEC Form 414 August 2026Common Stock · traded 14 August 2026 · filed 14 August 2026
- was granted 719,679 shares of Neogen (a derivative holding)SEC Form 414 August 2026Common Stock (Right to Buy) · traded 14 August 2026 · filed 14 August 2026
- ▲ bought on the open market 370 shares of NeogenSEC Form 46 August 2026Common Stock · traded 4 August 2026 · filed 6 August 2026
- ▲ bought on the open market 23 shares of NeogenSEC Form 417 February 2026Common Stock · traded 17 February 2026 · filed 17 February 2026
- ▲ bought on the open market 23 shares of NeogenSEC Form 417 February 2026Common Stock · traded 17 February 2026 · filed 17 February 2026
- ▲ bought on the open market 25 shares of NeogenSEC Form 42 February 2026Common Stock · traded 26 January 2026 · filed 2 February 2026
- ▲ bought on the open market 24 shares of NeogenSEC Form 42 February 2026Common Stock · traded 2 February 2026 · filed 2 February 2026
- ▲ bought on the open market 25 shares of NeogenSEC Form 42 February 2026Common Stock · traded 26 January 2026 · filed 2 February 2026
- ▲ bought on the open market 24 shares of NeogenSEC Form 42 February 2026Common Stock · traded 2 February 2026 · filed 2 February 2026
- ▲ bought on the open market 137 shares of NeogenSEC Form 416 January 2026Common Shares · traded 16 January 2026 · filed 16 January 2026
- ▲ bought on the open market 137 shares of NeogenSEC Form 416 January 2026Common Shares · traded 16 January 2026 · filed 16 January 2026
- ▲ bought on the open market 177 shares of NeogenSEC Form 47 November 2025Common Shares · traded 3 November 2025 · filed 7 November 2025
- was granted 1,065,042 shares of Neogen (a derivative holding)SEC Form 419 August 2025Common Stock (Right to Buy) · traded 15 August 2025 · filed 19 August 2025
- was granted 473,352 shares of Neogen (a derivative holding)SEC Form 419 August 2025Common Stock (Right to Buy) · traded 15 August 2025 · filed 19 August 2025
- was granted 184,162 shares of NeogenSEC Form 419 August 2025Common Stock · traded 15 August 2025 · filed 19 August 2025
- was granted 414,365 shares of NeogenSEC Form 419 August 2025Common Stock · traded 15 August 2025 · filed 19 August 2025
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.